Coroflo's innovative breastfeeding monitor, Coro, has won the prestigious Red Dot Award for Innovation, recognising its exceptional design and ability to accurately track breast milk intake. This award validates Coro's groundbreaking technology, which, through a convenient nipple shield...
Roswell Park investigators uncover evidence that could help make CDK4/6 inhibitors more effective BUFFALO, N.Y., July 7, 2025 /PRNewswire-PRWeb/ -- Preliminary results of an observational clinical trial underway at Roswell Park Comprehensive Cancer Center are shedding light on why some...
GlobalMed® was awarded this prestigious award in May 2025 for his exceptional dedication and service to Arizona's Veteran community. SCOTTSDALE, Ariz., July 7, 2025 /PRNewswire-PRWeb/ -- In Arizona, few honors stand as tall in the Veteran community as the Copper Eagle Award, bestowed...
Millions of members set to benefit from Zócalo Health's integrated care model as company expands East Coast reach BALTIMORE, July 7, 2025 /PRNewswire-PRWeb/ -- Zócalo Health, a community-based primary care provider dedicated to serving underserved and underrepresented patients with...
Jessica Cahen Earns Best Infomercial Award for Her Exceptional Presentation Touting the Aventura Florida Medical Practice's Dedication to the Diagnosis and Treatment of Vascular Diseases AVENTURA, Fla., July 7, 2025 /PRNewswire-PRWeb/ -- Vivid Vascular proudly announces that Marketing...
Based on the author's actual journey after a health issue disrupts his creative path as an artist and a poet as he explores a Croatian island SAN DIEGO, July 7, 2025 /PRNewswire-PRWeb/ -- Part travel narrative, part internal reckoning, author and artist Rod Engel shares a fictionalized...
The Pulmonary Hypertension Association visits Denver, Aug. 23-24, to raise awareness about pulmonary hypertension and support the local PH community through education, connection and support. WASHINGTON, July 7, 2025 /PRNewswire-PRWeb/ -- The Pulmonary Hypertension Association heads to...
The data from over 1,200 Idaho patients also show a 92% reduction in opioid use with addiction treatment that combines specialist providers, medication and regular lab testing. BOISE, Idaho, July 7, 2025 /PRNewswire-PRWeb/ -- Ideal Option, a national leader in outpatient...
Women We Admire is pleased to announce The Top 50 Women Chief Compliance Officers of 2025 NEW YORK, July 4, 2025 /PRNewswire-PRWeb/ -- Women We Admire is pleased to announce The Top 50 Women Chief Compliance Officers of 2025. These distinguished leaders serve at the intersection of...
The $100,000 Linda G. O'Bryant Prize will recognize bold new research frameworks for designing and testing conscious artificial intelligence. NOVATO, Calif., July 3, 2025 /PRNewswire-PRWeb/ -- The Institute of Noetic Sciences (IONS) proudly announces the third annual Linda G. O'Bryant...
StrideCare announces its expansion into Charleston, South Carolina through a strategic partnership with Coastal Vascular & Vein Center. This collaboration reinforces StrideCare's commitment to innovative, compassionate care while expanding access to expert treatment for vascular and foot...
Expanded facilities will enhance hands-on training and workforce readiness for future healthcare professionals. SANTA ANA, Calif., July 3, 2025 /PRNewswire-PRWeb/ -- CNI College, a leading provider of nursing and allied health education in Orange County, has expanded its Santa Ana campus...
ACA Pharma, an end-to-end commercialization partner for China & Southeast Asia, helps Eagle Pharmaceuticals secure regulatory approval in Macau for RYANODEX® in under 90 days. NEW YORK, July 3, 2025 /PRNewswire-PRWeb/ -- MACAU – ACA Pharma proudly announces the rapid regulatory approval...
JM Nutrition provides nutritional support by registered dietitians and nutritionists across Canada. You can now receive nutritional counselling like it should be: personalized, thorough and supportive. TORONTO, July 3, 2025 /PRNewswire-PRWeb/ -- JM Nutrition is pleased to announce that it...
The importance of earning this award highlights how a Right at Home franchise can help an owner create increased earning potential by reducing costs through shared resources and standardizing efficiencies. OMAHA, Neb., July 3, 2025 /PRNewswire-PRWeb/ -- Right at Home® is proud to announce...
In this free webinar, learn how dose-by-dose adherence monitoring with digital tools and timely interventions can significantly increase patient retention and improve overall compliance in CNS trials. Attendees will gain insight into how active, daily adherence monitoring with a built-in...
In this free webinar, learn about developing high-concentration, low-viscosity formulations and selecting the right delivery device for drugs. Attendees will gain insight into what goes in the development of drug delivery devices. The featured speakers will discuss how to accelerate...
In this free webinar, gain insight into the FDA's perspective on model-informed drug development (MIDD). Attendees will learn about pharmacokinetic/pharmacodynamic (PK/PD) modeling strategies and their benefits. The featured speakers will discuss the application of PK/PD modeling and...
Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, drug discovery & development and laboratory technology. TORONTO , July 3, 2025 /PRNewswire-PRWeb/ -- Stay on top of current hot topics through free webinars presented by leading experts in...
In this free webinar, learn about the importance of moving beyond BMI to incorporate a range of biomarkers in clinical trials for obesity to enhance the accuracy of obesity diagnosis, facilitate precision medicine and improve the prevention and treatment of obesity-related diseases. The...
On 25 June, the World Health Organization (WHO) concluded its participation in a 36-hour nuclear emergency exercise organized by the International Atomic Energy Agency (IAEA).
The exercise was part of the IAEA’s Level 3 Convention Exercise (ConvEx-3), the highest and most complex level of its emergency exercises. These large-scale exercises are conducted every three to five years to test emergency preparedness and response capacities and identify areas in need of improvement. The last ConvEx-3 exercise took place in 2021 in cooperation with the United Arab Emirates.
The exercise involved more than 75 countries and 10 international organizations and was based on a simulated accident at a nuclear power plant in Romania, resulting in the release of significant amounts of radioactive material. Participating countries and organizations exchanged information in real time, assessed evolving risks, coordinated communications, and decided on appropriate protective actions, including the medical response.
As part of the simulation, WHO set up an Incident Management Support Team composed of experts from country, regional and headquarters offices. The WHO teams liaised with national authorities to monitor the public health impact, developed public health messages on protective actions, and provided guidance on mental health support for affected communities and emergency responders.
New elements this year included the close coordination of protective measures by neighbouring countries Bulgaria and the Republic of Moldova, the deployment of international assistance missions and the additional challenge of cybersecurity threats. An expanded social media simulator was used to test crisis communication strategies.
By simulating high-risk cross-border nuclear emergencies, these exercises test existing structures and technical readiness, help build trust and strengthen a coordinated global response. WHO’s ongoing work to strengthen radiation protection of the public, patients and workers worldwide includes providing Member States with evidence-based guidance, tools and technical advice on public health issues related to ionizing and non-ionizing radiation.
Following the exercise, the IAEA will compile and publish a detailed review of best practices and areas for improvement. WHO will review the lessons learned and adjust processes accordingly.
The World Health Organization (WHO) today has launched a major new initiative urging countries to raise real prices on tobacco, alcohol, and sugary drinks by at least 50% by 2035 through health taxes in a move designed to curb chronic diseases and generate critical public revenue. The “3 by 35” Initiative comes at a time when health systems are under enormous strain from rising noncommunicable diseases (NCDs), shrinking development aid and growing public debt.
The consumption of tobacco, alcohol, and sugary drinks are fueling the NCD epidemic. NCDs, including heart disease, cancer, and diabetes, account for over 75% of all deaths worldwide. A recent report shows that a one-time 50% price increase on these products could prevent 50 million premature deaths over the next 50 years.
“Health taxes are one of the most efficient tools we have,” said Dr Jeremy Farrar, Assistant Director-General, Health Promotion and Disease Prevention and Control, WHO. “They cut the consumption of harmful products and create revenue governments can reinvest in health care, education, and social protection. It’s time to act.”
The Initiative has an ambitious but achievable goal of raising US$1 trillion over the next 10 years. Between 2012 and 2022, nearly 140 countries raised tobacco taxes, which resulted in an increase of real prices by over 50% on average, showing that large-scale change is possible.
From Colombia to South Africa, governments that have introduced health taxes have seen reduced consumption and increased revenue. Yet many countries continue to provide tax incentives to unhealthy industries, including tobacco. Moreover, long-term investment agreements with industry that restrict tobacco tax increases can further undermine national health goals. WHO encourages governments to review and avoid such exemptions to support effective tobacco control and protect public health.
Strong collaboration is at the heart of the “3 by 35” Initiative’s success. Led by WHO, the Initiative brings together a powerful group of global partners to help countries put health taxes into action. These organizations offer a mix of technical know-how, policy advice, and real-world experience. By working together, they aim to raise awareness about the benefits of health taxes and support efforts at the national level.
Many countries have expressed interest in transitioning toward more self-reliant, domestically funded health systems and are turning to WHO for guidance.
The “3 by 35” Initiative introduces key action areas to help countries, pairing proven health policies with best practices on implementation. These include direct support for country-led reforms with the following goals in mind:
Increase or introduce excise taxes on tobacco, alcohol, and sugary drinks to raise prices and reduce consumption, cutting future health costs and preventable deaths.
Mobilize domestic public resources to fund essential health and development programmes, including universal health coverage.
Strengthen multisectoral alliances by engaging ministries of finance and health, parliamentarians, civil society, and researchers to design and implement effective policies.
WHO is calling on countries, civil society, and development partners to support the “3 by 35” Initiative and commit to smarter, fairer taxation that protects health and accelerates progress toward the Sustainable Development Goals.
Today, Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO). This historic milestone follows nearly 70 years of commitment by the government and people of Suriname to eliminate the disease across its vast rainforests and diverse communities.
“WHO congratulates Suriname on this remarkable achievement,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This certification is a powerful affirmation of the principle that everyone—regardless of nationality, background, or migration status—deserves universal access to malaria diagnosis and treatment. Suriname’s steadfast commitment to health equity serves as an inspiration to all countries striving for a malaria-free future.”
With today’s announcement, a total of 46 countries and 1 territory have been certified as malaria-free by WHO, including 12 countries in the Region of the Americas.
“Suriname did what was needed to eliminate malaria—detecting and treating every case quickly, investigating to prevent spread, and engaging communities,” said Dr Jarbas Barbosa, Director of the Pan American Health Organization (PAHO), WHO’s regional office for the Americas. “This certification reflects years of sustained effort, especially reaching remote areas. It means future generations can grow up free from this potentially deadly disease.”
Certification of malaria elimination is granted by WHO when a country has proven, beyond reasonable doubt, that the chain of indigenous transmission has been interrupted nationwide for at least the previous three consecutive years.
Dr Amar Ramadhin, Minister of Health of Suriname, stated: "Being malaria-free means that our population is no longer at risk from malaria. Furthermore, eliminating malaria will have positive effects on our healthcare sector, boost the economy, and enhance tourism.
“At the same time, we recognize that maintaining this status requires ongoing vigilance. We must continue to take the necessary measures to prevent the reintroduction of malaria. We are proud that our communities are now protected, and we look forward to welcoming more visitors to our beautiful Suriname—while remaining fully committed to safeguarding these hard-won gains.”
Suriname’s malaria control efforts began in 1950s in the country’s densely-populated coastal areas, relying heavily on indoor spraying with the pesticide DDT and antimalarial treatment. By the 1960s, the coastal areas had become malaria-free and attention turned towards the country’s forested interior, home to diverse indigenous and tribal communities.
Although indoor spraying was successful in coastal areas, its impact was limited in the country's interior due to the prevalence of traditional open-style homes that offer minimal protection against mosquitoes. In 1974 malaria control in the interior was decentralized to Medische Zending, Suriname’s primary health care service, which recruited and trained healthcare workers from the local communities to provide early diagnosis and treatment.
The surge in mining activities, particularly gold mining which often involves travel between malaria-endemic areas, led to increases in malaria, reaching a peak of more than 15 000 cases in 2001, the highest transmission rates of malaria in the Americas.
Since 2005, with support from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the capacity to provide diagnosis was greatly expanded with both improvements in microscopy and the use of rapid diagnostic tests, particularly among mobile groups. Artemisinin-based treatments with primaquine were introduced in Suriname and neighboring countries through PAHO-led studies under the Amazon Malaria Initiative (AMI-RAVREDA), supported by the United States. Prevention among high-risk groups was also strengthened through the distribution of insecticide-treated nets funded by the Global Fund.
By 2006, malaria had drastically decreased among the indigenous populations, prompting Suriname to shift its focus to high-risk mobile populations in remote mining areas. To reach these groups—many of whom were migrants from neighboring endemic countries—the country established a network of Malaria Service Deliverers, recruited directly from the mining communities. These trained and supervised community workers provide free malaria diagnosis, treatment, and prevention services, playing a vital role in closing access gaps in hard-to-reach regions.
Through ensuring universal access to diagnosis and treatment regardless of legal status, deploying an extensive network of community health workers, and implementing nationwide malaria screening, including at border crossings, Suriname successfully eliminated malaria. The last locally transmitted case of Plasmodium falciparum malaria was recorded in 2018, followed by the final Plasmodium vivax case in 2021.
The government of Suriname has shown strong commitment to malaria elimination, including through the National Malaria Elimination Taskforce, Malaria Program, Malaria Elimination Fund, and cross-border collaboration with Brazil, Guyana and French Guiana. For many years PAHO/WHO, with the support of the U.S. Government, has provided technical cooperation throughout Suriname’s anti-malaria campaign. Since 2016 Suriname also participated in the “Elimination 2025” initiative – a group of countries identified by WHO as having the potential to eliminate malaria by 2025.
This success in Suriname is a demonstration that malaria elimination is possible in challenging contexts in the Amazon basin and in tropical continental countries. The country’s malaria-free certification plays a critical role in advancing PAHO's Disease Elimination Initiative which aims to eliminate more than 30 communicable diseases, including malaria, in countries of the Americas by 2030.
WHO malaria-free certification
The final decision on awarding a malaria-free certification is made by the WHO Director-General, based on a recommendation by the Technical Advisory Group on Malaria Elimination and Certification and validation from the Malaria Policy Advisory Group. For more on WHO’s malaria-free certification process, visit this link.
The World Health Organization (WHO) Commission on Social Connection has released its global report revealing that 1 in 6 people worldwide is affected by loneliness, with significant impacts on health and well-being. Loneliness is linked to an estimated 100 deaths every hour—more than 871 000 deaths annually. Strong social connections can lead to better health and longer life, the report says.
“In this Report, we pull back the curtain on loneliness and isolation as a defining challenge of our time. Our Commission lays out a road map for how we can build more connected lives and underscores the profound impact this can have on health, educational, and economic outcomes,” said Dr Vivek Murthy, Co-chair of the WHO Commission on Social Connection, and former Surgeon General of the United States of America.
WHO defines social connection as the ways people relate to and interact with others. Loneliness is described as the painful feeling that arises from a gap between desired and actual social connections, while social isolation refers to the objective lack of sufficient social connections.
“In this age when the possibilities to connect are endless, more and more people are finding themselves isolated and lonely," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "Apart from the toll it takes on individuals, families and communities, left unaddressed, loneliness and social isolation will continue to cost society billions in terms of health care, education, and employment. I welcome the Commission's report, which shines a light on the scale and impact of loneliness and isolation, and outlines key areas in which we can help people to reconnect in ways that matter most.”
Loneliness affects people of all ages, especially youth and people living in low- and middle-income countries (LMIC). Between 17–21% of individuals aged 13–29-year-olds reported feeling lonely, with the highest rates among teenagers. About 24% of people in low-income countries reported feeling lonely — twice the rate in high-income countries (about 11%).
“Even in a digitally connected world, many young people feel alone. As technology reshapes our lives, we must ensure it strengthens—not weakens—human connection. Our report shows that social connection must be integrated into all policies—from digital access to health, education, and employment,” said Chido Mpemba, Co-chair of the WHO Commission on Social Connection and Advisor to the African Union Chairperson.
While data on social isolation is more limited, it is estimated to affect up to 1 in 3 older adults and 1 in 4 adolescents. Some groups, such as people with disabilities, refugees or migrants, LGBTQ+ individuals, and indigenous groups and ethnic minorities, may face discrimination or additional barriers that make social connection harder.
Loneliness and social isolation have multiple causes. They include, for instance, poor health, low income and education, living alone, inadequate community infrastructure and public policies, and digital technologies. The report underscores the need for vigilance around the effects of excessive screen time or negative online interactions on the mental health and well-being of young people.
Social connection can protect health across the lifespan. It can reduce inflammation, lower the risk of serious health problems, foster mental health, and prevent early death. It can also strengthen the social fabric, contributing to making communities healthier, safer and more prosperous.
In contrast, loneliness and social isolation increase the risk of stroke, heart disease, diabetes, cognitive decline, and premature death. It also affects mental health, with people who are lonely twice as likely to get depressed. Loneliness can also lead to anxiety, and thoughts of self-harm or suicide.
The impacts extend to learning and employment. Teenagers who felt lonely were 22% more likely to get lower grades or qualifications. Adults who are lonely may find it harder to find or maintain employment and may earn less over time.
At a community level, loneliness undermines social cohesion and costs billions in lost productivity and health care. Communities with strong social bonds tend to be safer, healthier and more resilient, including in response to disasters.
The report of the WHO Commission on Social Connection outlines a roadmap for global action focusing on five key areas: policy, research, interventions, improved measurement (including developing a global Social Connection Index), and public engagement, to shift social norms and bolster a global movement for social connection.
Solutions to reduce loneliness and social isolation exist at multiple levels – national, community and individual – and range from raising awareness and changing national policies to strengthening social infrastructure (e.g., parks, libraries, cafés) and providing psychological interventions.
Most people know what it feels like to be lonely. And each person can make a difference through simple, everyday steps—like reaching out to a friend in need, putting away one’s phone to be fully present in conversation, greeting a neighbor, joining a local group, or volunteering. If the problem is more serious, finding out about available support and services for people who feel lonely is important.
The costs of social isolation and loneliness are high, but the benefits of social connection are far-reaching.
With the release of the Commission report, WHO calls on all Member States, communities and individuals to make social connection a public health priority.
The report launch follows the first-ever resolution on social connection, adopted by the World Health Assembly (WHA) in May 2025, which urges Member States to develop and implement evidence-based policies, programmes and strategies to raise awareness and promote positive social connection for mental and physical health. At the WHA, WHO also announced a new campaign called “ Knot Alone” to promote social connection for better health. Tune in to WHO’s social media channels to follow the campaign.
As part of its broader efforts, WHO has also launched the Social Connection Series to explore the lived experience of loneliness and social isolation. Learn more about the series here.
Tracking SDG 7: The Energy Progress Report 2025 finds that almost 92% of the world’s population now has basic access to electricity. Although this is an improvement since 2022, which saw the number of people without basic access decrease for the first time in a decade, over 666 million people remain without access, indicating that the current rate is insufficient to reach universal access by 2030. Clean cooking access is progressing but below the rates of progress seen in the 2010s, as efforts remain hobbled by setbacks during the Covid-19 pandemic, following energy price shocks, and debt crises.
Released today, the latest edition of the annual report that tracks progress towards Sustainable Development Goal (SDG) 7 highlights the role of distributed renewable energy (a combination of mini-grid and off-grid solar systems) to accelerate access, since the population remaining unconnected lives mostly in remote, lower-income, and fragile areas. Cost-effective and rapidly scalable, decentralised solutions are able to reach communities in such rural areas.
Decentralised solutions are also needed to increase access to clean cooking. With an estimated 1.5 billion people residing in rural areas still lacking access to clean cooking, the use of off-grid clean technologies, such as household biogas plants and mini-grids that facilitate electric cooking, can provide solutions that reduce health impacts caused by household air pollution. Over 670 million people remain without electricity access, and over 2 billion people remain dependent on polluting and hazardous fuels such as firewood and charcoal for their cooking needs.
Notable progress was made in different indicators. The international financial flows to developing countries in support of clean energy grew for the third year in a row to reach US$ 21.6 billion in 2023. Installed renewables capacity per capita continued to increase year-on-year to reach a new high of 341 watts per capita in developing countries, up from 155 watts in 2015.
Yet regional disparities persist, indicating that particular support is needed for developing regions. In sub-Saharan Africa – which lags behind across most indicators – renewables deployment has rapidly expanded but remains limited to 40 watts of installed capacity per capita on average which is only one-eighth of the average of other developing countries. Eighty-five percent of the global population without electricity access reside in the region, while four in five families are without access to clean cooking. And the number of people without clean cooking access in the region continues to grow at a rate of 14 million people yearly.
The report identified the lack of sufficient and affordable financing as a key reason for regional inequalities and slow progress. To build on the achievements to date and avoid any further regressions on access to electricity and clean cooking due to looming risks in global markets, the report calls for strengthened international cooperation of public and private sectors, to scale up financial support for developing countries, especially in sub-Saharan Africa. Urgent actions include reforms in multilateral and bilateral lending to expand the availability of public capital; more concessional finance mobilisation, grants, and risk mitigation instruments; improvement in risk tolerance among donors; as well as appropriate national energy planning and regulations.
The report will be presented to decision-makers at a special launch event on 16 July 2025 at the High-Level Political Forum on Sustainable Development in New York, which oversees progress on the SDGs.
Fatih Birol, Executive Director, International Energy Agency
“Despite progress in some parts of the world, the expansion of electricity and clean cooking access remains disappointingly slow, especially in Africa. This is contributing to millions of premature deaths each year linked to smoke inhalation, and is holding back development and education opportunities. Greater investment in clean cooking and electricity supply is urgently required, including support to reduce the cost of capital for projects.”
Francesco La Camera, Director-General, International Renewable Energy Agency
“Renewables have seen record growth in recent years, reminding the world of its affordability, scalability, and its role in further reducing energy poverty. But we must accelerate progress at this crunch time. This means overcoming challenges, which include infrastructure gaps. The lack of progress, especially on infrastructure, is a reflection of limited access to financing. Although international financial flows to developing countries in support of clean energy grew to US$ 21.6 billion in 2023, only two regions in the world have seen real progress in the financial flows. To close the access and infrastructure gaps, we need strengthened international cooperation to scale up affordable financing and impact–driven capital for the least developed and developing countries.”
Stefan Schweinfest, Director, United Nations Statistics Division
“This year’s report shows that now is the time to come together to build on existing achievements and scale up our efforts. Despite advancements in increasing renewables-based electricity, which now makes up almost 30 percent of global electricity consumption, the use of renewables for other energy-related purposes remains stagnant. While energy intensity improved in 2022, overall progress remains weak, threatening economic growth and the energy efficiency goals agreed upon at COP28. The clock is ticking. The findings of this year’s report should serve as a rallying point, to rapidly mobilize efforts and investments, so that together, we ensure sustainable energy for all by 2030.”
Guangzhe Chen, Vice President for Infrastructure, World Bank
"As we approach the five-year mark to achieve the SDG7 targets, it is imperative to accelerate the deployment of electricity connections, especially in Sub-Saharan Africa, where 85% of the 666 million people lacking access reside. As part of the Mission 300 movement, 12 African nations have launched national energy compacts, in which they commit to substantial reforms to lower costs of generation and transmission, and scale up distributed renewable energy solutions. Initiatives such as this unite governments, the private sector, and development partners in a collaborative effort.
Dr Tedros Adhanom Ghebreyesus, WHO Director-General, World Health Organization
“The same pollutants that are poisoning our planet are also poisoning people, contributing to millions of deaths each year from cardiovascular and respiratory diseases, particularly among the most vulnerable, including women and children," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "We urgently need scaled-up action and investment in clean cooking solutions to protect the health of both people and planet—now and in the future.”
This report is published by the SDG 7 custodian agencies, the International Energy Agency (IEA), the International Renewable Energy Agency (IRENA), the United Nations Statistics Division (UNSD), the World Bank, and the World Health Organization (WHO) and aims to provide the international community with a global dashboard to register progress on energy access, energy efficiency, renewable energy and international cooperation to advance SDG 7.
This year’s edition was chaired by IRENA.
The report can be downloaded at https://trackingsdg7.esmap.org/
Funding for the report was provided by the World Bank’s Energy Sector Management Assistance Program (ESMAP).
On 26 June 2025, this news release was edited to correct an error in the quote from Guangzhe Chen, Vice President for Infrastructure, World Bank. The original version had incorrectly stated that half of the 666 million people lacking access to electricity reside in sub-Saharan Africa. The correct proportion is 85%.
The World Health Organization (WHO) today released its report on the Global Tobacco Epidemic 2025 at the World Conference on Tobacco Control in Dublin, warning that action is needed to maintain and accelerate progress in tobacco control as rising industry interference challenges tobacco policies and control efforts.
The report focuses on the six proven WHO MPOWER tobacco control measures to reduce tobacco use, which claims over 7 million lives a year:
Since 2007, 155 countries have implemented at least one of the WHO MPOWER tobacco control measures to reduce tobacco use at best-practice level. Today, over 6.1 billion people, three-quarters of the world’s population, are protected by at least one such policy, compared to just 1 billion in 2007. Four countries have implemented the full MPOWER package: Brazil, Mauritius, the Netherlands (Kingdom of the), and Türkiye. Seven countries are just one measure away from achieving the full implementation of the MPOWER package, signifying the highest level of tobacco control, including Ethiopia, Ireland, Jordan, Mexico, New Zealand, Slovenia and Spain.
However, there are major gaps. Forty countries still have no MPOWER measure at best-practice level and more than 30 countries allow cigarette sales without mandatory health warnings.
“Twenty years since the adoption of the WHO Framework Convention on Tobacco Control, we have many successes to celebrate, but the tobacco industry continues to evolve and so must we,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “By uniting science, policy and political will, we can create a world where tobacco no longer claims lives, damages economies or steals futures. Together, we can end the tobacco epidemic.”
The WHO Global Tobacco Epidemic 2025 report, developed with support from Bloomberg Philanthropies, was launched during the 2025 Bloomberg Philanthropies Awards for Global Tobacco Control. The awards celebrated several governments and nongovernmental organizations (NGOs) making progress to reduce tobacco use.
“Since Bloomberg Philanthropies started supporting global tobacco control efforts in 2007, there has been a sea change in the way countries prevent tobacco use, but there is still a long way to go,” said Michael R. Bloomberg, founder of Bloomberg LP and Bloomberg Philanthropies and WHO Global Ambassador for Noncommunicable Diseases and Injuries. “Bloomberg Philanthropies remains fully committed to WHO’s urgent work – and to saving millions more lives together.”
The WHO Global Tobacco Epidemic 2025 report reveals that the most striking gains have been in graphic health warnings, one of the key measures under the WHO Framework Convention on Tobacco Control (FCTC), that make the harms of tobacco impossible to ignore:
WHO warns, however, that enforcement is inconsistent, and smokeless tobacco packaging remains poorly regulated. The new report is accompanied by a new data portal that tracks country-by-country progress between 2007–2025.
Despite their effectiveness, 110 countries haven’t run anti-tobacco campaigns since 2022. However, 36% of the global population now lives in countries that have run best-practice campaigns, up from just 19% in 2022. WHO urges countries to invest in message-tested and evaluated campaigns.
Taxes, quit services and advertising bans have been expanding, but many improvements are needed:
Around 1.3 million people die from second-hand smoke every year. Today, 79 countries have implemented comprehensive smoke-free environments, covering one-third of the world’s population. Since 2022, six additional countries (Cook Islands, Indonesia, Malaysia, Sierra Leone, Slovenia and Uzbekistan) have adopted strong smoke-free laws, despite industry resistance, particularly in hospitality venues.
There has been a growing trend to regulate the use of e-cigarettes or ENDS – Electronic Nicotine Delivery Systems. The number of countries regulating or banning ENDS has grown from 122 in 2022 to 133 in 2024, a clear signal of increased attention to these products. However, over 60 countries still lack any regulations on ENDS.
WHO is calling for urgent action in areas where momentum is lagging. “Governments must act boldly to close remaining gaps, strengthen enforcement, and invest in the proven tools that save lives. WHO calls on all countries to accelerate progress on MPOWER and ensure that no one is left behind in the fight against tobacco,” said Dr Ruediger Krech, Director of Health Promotion.
The World Health Organization (WHO) today released its first-ever global guideline on the management of sickle cell disease (SCD) during pregnancy, addressing a critical and growing health challenge that can have life-threatening consequences for both women and babies.
SCD is a group of inherited blood disorders characterized by abnormally shaped red blood cells that resemble crescents or sickles. These cells can block blood flow, causing severe anaemia, episodes of severe pain, recurrent infections, as well as medical emergencies like strokes, sepsis or organ failures.
Health risks associated with SCD intensify during pregnancy, due to heightened demands on the body’s oxygen and nutrient supply. Women with SCD face a 4- to 11-fold higher likelihood of maternal death than those without. They are more likely to experience obstetric complications like pre-eclampsia, while their babies are at greater risk of stillbirth or being born early or small.
“With quality health care, women with inherited blood disorders like sickle cell disease can have safe and healthy pregnancies and births,” said Dr Pascale Allotey, Director for Sexual and Reproductive Health and Research at WHO and the United Nations’ Special Programme for Human Reproduction (HRP). “This new guideline aims to improve pregnancy outcomes for those affected. With sickle cell on the rise, more investment is urgently needed to expand access to evidence-based treatments during pregnancy as well as diagnosis and information about this neglected disease.”
There are around 7.7 million people living with SCD worldwide – a figure that has increased by over 40% since 2000. SCD is estimated to cause over 375 000 deaths each year. The disease is most prevalent in malaria-endemic regions, particularly sub-Saharan Africa--which accounts for around 8 in 10 cases--as well as parts of the Middle East, the Caribbean, and South Asia. With population movements and improvements in life expectancy, the sickle cell gene is also becoming more widespread globally, meaning more maternity care providers need to know how to manage the disease.
Until now, clinical guidance for managing SCD in pregnancy has largely drawn on protocols from high-income countries. WHO’s new guideline aims to provide evidence-based recommendations that are also relevant for low- and middle-income settings, where most cases and deaths from the disease occur. Accordingly, the guideline includes over 20 recommendations spanning:
Critically, the guideline highlights the need for respectful, individualized care, adapted according to women’s unique needs, medical histories and preferences. It also addresses the importance of tackling stigma and discrimination within healthcare settings, which can be a major challenge for people with SCD in several countries around the world.
“It’s essential that women with sickle cell disease can discuss their care options early in pregnancy—or ideally before—with knowledgeable providers,” said Dr Doris Chou, Medical Officer and lead author of the guideline. “This supports informed decisions about any treatment options to continue or adopt, as well as agree on ways of handling potential complications, so as to optimize outcomes for the woman, her pregnancy, and her baby.”
Given the complex nature of these disorders, if a pregnant woman has SCD, the guideline notes the importance of involving skilled and knowledgeable personnel in her care team. These may include specialists like haemotologists as well as midwives, paediatricians and obstetrician-gynecologists who provide services for reproductive and newborn health.
SCD is a neglected health condition that remains considerably under-funded and under-researched, despite its growing prevalence worldwide. While treatment options are improving for the general population, the guideline underscores the urgent need for more research into the safety and efficacy of SCD treatments for pregnant and breastfeeding women – populations that have historically been excluded from clinical trials.
This publication is the first in a new WHO series on managing noncommunicable diseases in pregnancy. Future guidelines will address cardiovascular conditions, diabetes, respiratory diseases, mental health disorders and substance use. Chronic diseases are increasingly recognized as major contributors to maternal and newborn deaths and ill health.
The Spanish Agency for International Development Cooperation (AECID) and the World Health Organization (WHO) today signed a new agreement and contribution of €5.25 million to support key WHO initiatives.
“Spain has long been a close and steadfast partner to WHO and global health," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "We thank Spain for its increased flexible funding of our work, in doing so helping WHO be stronger and more independent and allowing us to deliver the services that countries and communities need from us.”
This year, Spain’s commitment to global health entered a new chapter as it returned to the WHO Executive Board for the 2025–2028 term, nearly two decades since its last membership. This renewed engagement is supported by the country’s new Global Health Strategy, launched on 27 May 2025.
This is underscored by today’s signing of a new agreement between Spain and WHO and a growing collaboration between both partners. At the heart of this effort is the Spanish Agency for International Development Cooperation (AECID), under the leadership of Mr Antón Leis; AECID has significantly stepped up flexible and strategic funding for WHO activities.
AECID's €5.25 million contribution to WHO is part of a broader €60 million pledge announced by Prime Minister Pedro Sánchez in November 2024. Spain’s multi-year commitment also includes support for critical health programmes in countries such as Jordan, Mali, and Sudan, as well as other global initiatives.
Looking forward, Spain will host the 4th International Conference on Financing for Development (FFD4) in Seville, 30 June–3 July 2025, where it aims to elevate health financing as a core development priority. A high-level special event – co-sponsored by WHO and featuring leaders from global health, finance, and academia – will call for bold action through the “Health financing for a safe and sustainable economy: towards Seville health financing agenda for action.”
The Director-General of the World Health Organization (WHO), following the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee regarding the upsurge of mpox 2024, held on 5 June 2025, from 12:00 to 17:00 CEST, concurs with its advice that the event continues to meet the criteria of a public health emergency of international concern and, considering the advice of the Committee, he is hereby issuing a revised set of temporary recommendations.
The WHO Director-General expresses his most sincere gratitude to the Chair, Members, and Advisors of the Committee. The proceeding of the fourth meeting of the Committee will be shared with States Parties to the IHR and published in the coming days.
---------
These temporary recommendations are issued to States Parties experiencing the transmission of monkeypox virus (MPXV), including, but not limited to, those where there is sustained community transmission, and where there are clusters of cases or sporadic travel-related cases of MPXV clade Ib.
They are intended to be implemented by those States Parties in addition to the current standing recommendations for mpox, valid until 20 August 2025.
In the context of the global efforts to prevent and control the spread of mpox disease outlined in the WHO Strategic framework for enhancing prevention and control of mpox: 2024–2027, the aforementioned standing recommendations apply to all States Parties.
All current WHO interim technical guidance can be accessed on this page of the WHO website. WHO evidence-based guidance has been and will continue to be updated in line with the evolving situation, updated scientific evidence, and WHO risk assessment to support States Parties in the implementation of the WHO Strategic Framework for enhancing mpox prevention and control.
Pursuant to Article 3 Principle of the International Health Regulations (2005) (IHR), the implementation of these temporary recommendations, as well as of the standing recommendations for mpox, by States Parties shall be with full respect for the dignity, human rights and fundamental freedoms of persons, in line with the principles set out in Article 3 of the IHR.
---------
Note: The text in backets next to each temporary recommendation indicates the status with respect to the set of temporary recommendations issued on 27 November 2024.
Emergency coordination
Collaborative surveillance
Safe and scalable clinical care
International traffic
Vaccination
Community protection
Governance and financing
Addressing research gaps
Reporting on the implementation of temporary recommendations